Emerging and Practice-Changing Directions in Gynecologic Malignances Involving Combination Therapies With Immune Checkpoint Inhibitors
Susana Campos, MD, MPH
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
Nicoletta Colombo, MD
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
Ritu Salani, MD, MBA
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.